Related Experiment Video

Updated: Feb 27, 2026

Quantitating Iron Transport Across the Mouse Placenta In Vivo Using Nonradioactive Iron Isotopes
08:45

Quantitating Iron Transport Across the Mouse Placenta In Vivo Using Nonradioactive Iron Isotopes

Published on: May 10, 2022

2.5K

The iron paradox: a case of acaeruloplasminaemia

J Williamson1, J Holt

  • 1J Williamson, Neurology Department, The Walton Centre NHS Foundation Trust, Fazakerley, Liverpool L9 7LJ, UK.

The Journal of the Royal College of Physicians of Edinburgh
|July 5, 2017
PubMed

Insights

Acaeruloplasminaemia is a rare neurodegenerative disease causing iron buildup in the brain and body due to caeruloplasmin gene dysfunction. This case study details a patient

Area of Science:

  • Neurogenetics
  • Neurodegenerative Diseases
  • Iron Metabolism Disorders

Background:

  • Acaeruloplasminaemia is a rare, inherited neurodegenerative disorder.
  • It is characterized by the dysfunction of the ceruloplasmin gene (CP).
  • This dysfunction leads to excessive iron accumulation in the brain and systemic iron overload.

Observation:

  • A 53-year-old male presented with a 4-year history of progressive neuropsychiatric symptoms.
  • Clinical presentation included neurological and psychiatric manifestations.
  • Diagnostic workup revealed characteristic findings supporting acaeruloplasminaemia.

Findings:

  • Confirmed diagnosis of acaeruloplasminaemia.
  • Detailed analysis of clinical features, laboratory results, and radiological findings.
  • Identification of key diagnostic pointers for differentiating from similar conditions.

Implications:

  • Highlights the importance of recognizing rare neurodegenerative disorders.
  • Provides insights into the clinical presentation and diagnostic challenges of acaeruloplasminaemia.
  • Aids clinicians in differentiating this condition from other causes of iron accumulation and neurological symptoms.
Keywords:
acaeruloplasminaemiabrain iron accumulationcaeruloplasmin

More Related Videos

Measurement of Heme Synthesis Levels in Mammalian Cells09:43

Measurement of Heme Synthesis Levels in Mammalian Cells

Published on: July 9, 2015

12.6K
Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management05:35

Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management

Published on: January 19, 2024

1.6K

Related Concept Videos

Disorders of Erythrocytes01:27

Disorders of Erythrocytes

Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
2.4K
Lifecycle of Erythrocytes01:22

Lifecycle of Erythrocytes

Erythrocytes, also known as red blood cells, constantly move through blood capillaries. As a result, they damage their plasma membrane due to the continuous friction. Typically, after 100 to 120 days, erythrocytes become rigid and fragile as they wear out. As they pass through small vessels in the spleen and liver, they can get trapped and break apart into fragments.
The resident phagocytic macrophages deal with these damaged cells by engulfing them and separating their globin and heme groups....
5.6K
Erythropoiesis01:14

Erythropoiesis

Red blood cells  (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia,...
6.3K
Factors Affecting Erythropoiesis01:24

Factors Affecting Erythropoiesis

The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
6.4K
The Early Endosome: Endocytosis of Transferrin01:28

The Early Endosome: Endocytosis of Transferrin

Essential proteins such as insulin or low-density lipoprotein (LDL) and micronutrients such as iron enter a eukaryotic cell through receptor-mediated endocytosis. Subsequently, the early endosomes fuse with the vesicles containing such receptor-ligand complexes and play a vital role in sorting the incoming ligands and receptors. While the ligands are either degraded inside the vesicle or released into the cytosol, their receptors are returned to the plasma membrane for further rounds of...
5.0K
Hemoglobin01:24

Hemoglobin

Hemoglobin is a globular protein made up of four subunits. Two of these subunits are alpha chains, and the other two are beta chains. Each subunit contains a molecule of heme, which has an iron atom and can bind to oxygen. When an oxygen molecule binds to one heme group, it changes the shape of hemoglobin, making it easier for the other heme groups to bind oxygen as well.
When all four heme groups are bound to oxygen, the resulting molecule is called oxyhemoglobin. As a result, arterial blood...
9.2K